Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
AGA releases POWER – an obesity practice guide for gastroenterologists
A new practice guide from the American Gastroenterological Association aims to help gastroenterologists engage in a multidisciplinary effort to...
News
Venetoclax produces durable effects in relapsed/refractory CLL
ORLANDO – Venetoclax may provide durable responses – even with treatment discontinuation – in patients with relapsed or refractory chronic...
News
Advanced CLL treatment approach depends on comorbidity burden
The choice of first-line therapy in symptomatic chronic lymphocytic leukemia patients depends largely on comorbidity burden.
News
NCCN: Myelofibrosis guideline is first in series on MPNs
ORLANDO – A guideline published in December 2016 for the diagnostic work-up of myeloproliferative neoplasms and for the management of...
Video
VIDEO: Striking improvement in PFS with olaparib for ovarian cancer
NATIONAL HARBOR, MD. – Maintenance therapy with the first-in-class PARP inhibitor olaparib was associated with a striking improvement in...
News
WPR may benefit patients with stage IVB cervical cancer
NATIONAL HARBOR, MD. – Whole pelvic radiation delivered in addition to chemotherapy in women who present with stage IVB cervical cancer confers...
News
Replacement factors, bypassing agents safely manage fitusiran bleed events
Fitusiran appears to promote hemostasis and reduce the frequency of bleeding in hemophilia.
Video
VIDEO: Rucaparib benefits HGOC with BRCA mutations
NATIONAL HARBOR, MD. – The PARP inhibitor rucaparib is safe and effective in patients with primary platinum-sensitive high-grade ovarian carcinoma...
News
Post-transplant drug combo eyed for high-risk AML
Azacitadine and valproic acid can be safely coadministered as maintenance therapy after allogeneic stem cell transplant in patients with high-risk...
News
Mixed leukemias can benefit from allo-HST
Allogeneic hematopoietic stem cell transplantation using a matched donor is a valid treatment option–and potential cure–for leukemias with markers...
News
Pre- and post-HCT MRD levels predict ALL survival
ORLANDO – Is there a way to predict ALL survival in children?
News
Promising ibrutinib data prompt frontline cGVHD therapy study
Ibrutinib was associated with clinically meaningful and durable responses in patients with chronic graft-versus-host disease that did not respond...
Article
Follistatin, endoglin predict postallogeneic HCT NRM
ORLANDO – Follistatin and endoglin levels at posttransplant day 28 predict 1-year nonrelapse mortality in patients who have undergone...
Article
FIRST trial: Education unaffected by flexible duty hours
Flexible duty hour policies did not impact general surgery resident performance on examinations in 2015 or 2016.
Article
Phase III trial: VZV protects auto-HCT patients
ORLANDO – An inactivated VZV vaccine for adults undergoing autologous hematopoietic stem cell transplantation has proven safe and effective.